Up Next
Back to Show
PBS News Hour
What we know about Moderna's COVID-19 vaccine candidate
The drug company Moderna has released encouraging data from research on its COVID-19 vaccine candidate. The research has not yet been published in a peer-reviewed medical journal, but it is nonetheless raising hopes. Noubar Afeyan is a co-founder and chairman of Moderna and the CEO of Flagship Pioneering, a venture capital firm that helped launch Moderna. He joins Judy Woodruff to discuss.
Support Provided By
57:46
February 18, 2026 - PBS News Hour full episode
57:46
February 17, 2026 - PBS News Hour full episode
57:46
February 16, 2026 - PBS News Hour full episode
57:46
February 13, 2026 - PBS News Hour full episode
57:46
February 12, 2026 - PBS News Hour full episode
57:46
February 11, 2026 - PBS News Hour full episode
57:46
February 10, 2026 - PBS News Hour full episode
56:45
February 9, 2026 - PBS News Hour full episode
57:46
February 6, 2026 - PBS News Hour full episode
57:46
February 5, 2026 - PBS News Hour full episode
56:44
February 4, 2026 - PBS News Hour full episode
57:46
February 3, 2026 - PBS News Hour full episode